Poll: Which aspects of hair loss awareness do you feel most need improvement?
This year, during Alopecia Awareness Month, we’d like to hear your thoughts on the action points we need to take to raise awareness of alopecia. Click here to take this week’s survey.
Deuclavacitinib: 1 year in review
As deuclavacitinib crosses the one-year milestone of approval, clinicians continue to monitor real-world performance in patients.
World Trade Center 9/11 rescue workers show increased risk of melanoma
From 2005 to 2015, rescue workers had a higher incidence of malignant melanoma compared to the general population in New York State.
Steven Dayan, MD, FACS: Prioritizing Patient Satisfaction in Cosmetic Dermatology
Steven Dayan, MD, FACS, lead author of a recent study on high patient satisfaction after treatment with botulinum toxin, discusses the importance of putting patient satisfaction at the forefront of cosmetic dermatology. .
Mallinckrodt receives FDA label update for StrataGraft xenograft requirements
The FDA no longer restricts the donation of human cells, tissues, cell- or tissue-based products, breast milk, eggs, sperm, or organs for transplantation into patients undergoing StrataGraft.
Seek research and insight: Share your insights about atopic dermatitis and eczema with us
Share your insights ahead of National Eczema Awareness Month in October by emailing our team at DTEditor@mmhgroup.com.
Spotlight on innovation and considerations
As September marks the one-year anniversary of the drug’s approval, a panel of leading dermatologists is discussing the efficacy and considerations of treating plaque psoriasis with deuclavacitinib.
Arctis files NDA for Roflumilast cream for the treatment of atopic dermatitis in patients aged 6 years and older
This filing follows the publication of recent long-term data for the drug in patients 6 years of age and older.
Izoquivep fails in Phase 2B/3 Hidradenitis suppurativa trial
The IL-17A inhibitor did not meet the primary endpoint of the Phase 2b/3 clinical trial.
Portela Pointer: Moisturizer for every skin type
This week on Pointers With Portela, 208SkinDoc recommends products for dry, oily, sensitive, and acne-prone skin types.
Donepezil patch shows good results in skin irritation test
In studies, donepezil transdermal systems for treating dementia showed no or minimal skin irritation.
Finasteride and hydroxychloroquine are thought to be equally effective in treating frontal fibrosing alopecia
Researchers compared the effectiveness of the two treatments and found them to be comparable in terms of safety, efficacy, and tolerability.
Successful treatment of folliculitis through surgical excision
After 17 months, the patient showed no signs of remission.
Be proactive about aging
In this month’s Letter from the Editor, Zoe Diana Draelos, MD, explains why aging is the culmination of a disease process and why we should take further steps to address it.
Confronting racial disparities in dermatology education
To further discuss changes in skin color expression in dermatology, Christopher Bunick, MD, and Shawn Kwatra, MD, review how they have seen changes in skin color expression in their own experiences.
Phase 1b study of rezpegaldesleukin in moderate-to-severe Alzheimer’s disease meets clinical efficacy endpoints
Nektar Therapeutics announced promising and statistically significant results including meeting endpoints for BSA, DLQI, and POEM in patients with atopic dermatitis.
Frontline Forum Part 1: Improving Basal Cell Carcinoma Management
In part 1 of this Frontline Forum series, Brent Moody, MD. Sarah Aaron, MD. Justin Cohen, DO; Emily Lewis, MD, MPH. and Todd Schlesinger, MD, discuss nonsurgical treatment options for BCC management, dose titration for systemic treatment, and combinations of hedgehog pathway inhibitors and immunotherapy.
The use of high-frequency ultrasound increases the diagnostic accuracy and certainty of subcutaneous lesions
According to the researchers, the uncertainty of invisible subcutaneous lesions such as epidermoid cysts, lipomas, pilarimas, hemangiomas, and DFSP can be reduced with the use of HFUS.
Journal Digest: September 13th
This week’s collection of the latest dermatology research features case reviews of sterile facial granulomas, chronic spontaneous urticaria and IgE, crusted scabies, and the safety and tolerability of onabotulinumtoxinA.
Rosehip oil showed significant improvement in scar healing
The treatment group showed faster healing and lower incidence of erythema than the control group.
“Moving Ahead” campaign raises awareness of atopic dermatitis
Almiral’s World Atopic Eczema Day initiative highlights experiences and facts about atopic dermatitis.
Maximize your device’s options for acne and acne scarring
Laser and microneedling treatments for acne and acne scars have increased in recent years, providing more options for patients.
Atopic dermatitis and systemic inflammation are not associated with dementia risk
According to the researchers, only three studies have previously investigated the potential link between AD and dementia, and findings have been inconsistent.
First patient administered in Phase 2 trial of bempikivert for alopecia areata
Bempikivert offers a new approach to treating the disease by blocking signaling pathways.
Understanding the role of amino acids and proteins in skin care
In this month’s Cosmetic Conundrums column, Dr. Zoe Diana Draelos discusses peptides and their use in skin care.
Long pulse ND:YAG laser effective for treatment of planar warts
In a study of 19 patients, laser treatment resulted in an excellent response in 86.36% of participants, with 78.94% achieving a complete response.
Insights into the next aesthetic with Katie Martin, PA
Martin presented Clinical Pearls on Business Management and Facial Balance in Dallas, Texas.
Dermatological concerns and disparities among members of the Hispanic community
This Hispanic Heritage Month, Dermatology Times examines the unique dermatology concerns and disparities faced by members of the Hispanic community.
Frontline Forum Part 2: Improving Basal Cell Carcinoma Management
In part two of this Frontline Forum series, Brent Moody, MD. Sarah Aaron, MD. Justin Cohen, DO; Emily Lewis, MD, MPH. and Todd Schlesinger, MD, discuss nonsurgical treatment options for BCC management, dose titration for systemic treatment, and combinations of hedgehog pathway inhibitors and immunotherapy.
Lebrikizumab receives positive opinions for the treatment of atopic dermatitis in Europe
Skin clearance and itch relief were maintained through 1 year of treatment with monthly maintenance.
Skin of Color Resources for Clinicians
Websites and educational materials are available to support clinicians in treating patients with skin of color.
GRAPPA continues to advance care for patients with plaque psoriasis
The Psoriasis and Psoriatic Arthritis Research and Evaluation Group provides an opportunity for clinicians to share knowledge and research.
https://www.dermatologytimes.com/view/the-weekly-roundup-september-11-15
